Cargando…
Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
BACKGROUND: Alzheimer's disease (AD) accompanied by psychotic symptoms (PS) has a poor prognosis and may be associated with imbalances in key neural proteins such as alpha-synuclein (AS). AIM: The aim of the study was to evaluate the diagnostic validity of AS levels in the cerebrospinal fluid (...
Autores principales: | Monge-García, Sonia, García-Ayllón, María-Salud, Sánchez-Payá, José, Gasparini-Berenguer, Ruth, Cortés-Gómez, María-Ángeles, Sáez-Valero, Javier, Monge-Argilés, José-Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244520/ https://www.ncbi.nlm.nih.gov/pubmed/37292130 http://dx.doi.org/10.3389/fneur.2023.1124145 |
Ejemplares similares
-
Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
por: Monge-García, Victoria, et al.
Publicado: (2021) -
Comparison of Two Analytical Platforms for CSF Biomarkers of Alzheimer's Disease
por: Monge-Argilés, Jose Antonio, et al.
Publicado: (2014) -
Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
por: Monge-Argilés, J. A., et al.
Publicado: (2016) -
CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
por: Huang, Jeffrey T.-J., et al.
Publicado: (2007) -
Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015)